Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Summary

The purpose of this study is to determine whether exenatide can cause weight loss in patients with a history of craniopharyngioma or other brain lesion.

Timeline

Start

2012-06

Primary completion

2015-03

Completion

2015-03

Publications

• Results Lomenick JP, Buchowski MS, Shoemaker AH. A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity. Obesity (Silver Spring). 2016 Jun;24(6):1222-5. doi: 10.1002/oby.21493. Epub 2016 May 2.

Drugs

Indications